Share Name Share Symbol Market Type Share ISIN Share Description
Fevertree Drinks LSE:FEVR London Ordinary Share GB00BRJ9BJ26 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -20.00p -0.88% 2,240.00p 2,236.00p 2,240.00p 2,255.00p 2,225.00p 2,250.00p 374,837 16:35:26
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Beverages 102.2 34.3 23.9 93.9 2,581.40

Fevertree (FEVR) Latest News

More Fevertree News
Fevertree Takeover Rumours

Fevertree (FEVR) Share Charts

1 Year Fevertree Chart

1 Year Fevertree Chart

1 Month Fevertree Chart

1 Month Fevertree Chart

Intraday Fevertree Chart

Intraday Fevertree Chart

Fevertree (FEVR) Discussions and Chat

Fevertree Forums and Chat

Date Time Title Posts
26/9/201719:06FEVER TREE with chart1,000
21/9/201713:17Fevertree Drinks PLC (Fever-Tree)1,235
07/11/201423:50Is Fever Tree fairly Valued?-

Add a New Thread

Fevertree (FEVR) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
16:12:502,236.63731,632.74O
16:11:302,240.102,06546,258.08O
16:09:122,240.922,13247,776.40O
16:08:462,236.38521,162.92O
16:07:272,236.0253511,962.73O
View all Fevertree trades in real-time

Fevertree (FEVR) Top Chat Posts

DateSubject
26/9/2017
09:20
Fevertree Daily Update: Fevertree Drinks is listed in the Beverages sector of the London Stock Exchange with ticker FEVR. The last closing price for Fevertree was 2,260p.
Fevertree Drinks has a 4 week average price of 2,114p and a 12 week average price of 1,674p.
The 1 year high share price is 2,506p while the 1 year low share price is currently 934p.
There are currently 115,240,896 shares in issue and the average daily traded volume is 661,403 shares. The market capitalisation of Fevertree Drinks is £2,581,396,070.40.
25/9/2017
11:06
christh: Fevertree is heading upwards to £30. Although there is a lot of ground to cover to make up for the lost ground, we'll see a surge for new highs. The market is now numb but a growth stock heading for new markets (China,India) will wake the market up. SEE THIS hTtps://www.thedrinksbusiness.com/2017/08/fever-tree-to-tap-into-china-market/ New products have been launched and new ones are prepared. Production increase to meet demand. SEE THIS https://www.ft.com/content/7d555532-7119-11e7-93ff-99f383b09ff9 OR SEE THIS hTtp://www.telegraph.co.uk/business/2017/07/25/fever-tree-continues-fizz-raises-profit-forecasts/ As always estimated earnings will be much higher and maybe treble or quadruple previous year. These are the facts. Look forward to the £30 share price.
17/9/2017
18:43
christh: Good afternoon, Our readership will know that we have been fans of Fevertree for a long -time, based upon their momentum driven nature and the strong historical tendency of investors to buy the dip. With the FTSE slumping on Friday we now believe the -14.20% fall in Fevertree's share price from a high of 2,506p on the 4th September to Friday's low of 2,150p represents another opportunity to buy. We should be clear that this is not fundamentally driven, as the shares are definitely not cheap on a valuation basis, but we still believe the historical precedent for investors to buy the shares on material weakness stands. We target a +14% move higher back to the 2,500p level. Petra Asset Management
15/9/2017
14:13
christh: I wrote to the directors this morning and received a reply just now ---------------------------------------------------------------------- Dear Mr xxxxxxxx, I am writing to you in relation to your email to Fever-Tree this morning. Apologies it has taken some time to get back to you. The Company knows no reason for the fall in the share price and understands your frustration. What I can say in relation to current trading is that if the Company has an obligation to update the market if it has information regarding its trading that could be deemed price sensitive (both from a positive or negative standpoint). The Company’s last trading update at the end of July contained the following update from the CEO – “We are delighted to report another strong performance in the first half of 2017, continuing the momentum seen in 2016 We achieved growth in all our regions, driven by further distribution gains and underlying rate of sales growth as the two key trends of premiumisation and mixability continue to gather pace globally. “We continue to invest and improve our infrastructure, relationships with key suppliers and customers as well as adding to our senior team. The strength of our brand and first mover advantage means we are well positioned as the opportunity for premium mixers continues to gather momentum across our key markets. Given the strong performance in the first half of the year, the Board anticipates that the outcome for the full year will be materially ahead of its expectations.”” I am sorry you feel there has not been more news from the Company but I can assure you management is focused on continue to drive value for all shareholders. I would be very happy to answer any further questions you have and can be contacted on the below number or would be happy to give you a call. Regards Oliver Winters
12/9/2017
08:50
christh: Why Fevertree shares have ‘plenty more growth to come’ News 5 May 2017 Alan Rowsell, who runs the high-performing Standard Life Global Smaller Companies Fund, has revealed the reasons why he keeps owning Fevertree shares, despite the enormous share price gains. Rowsell remarked that since he bought the shares in Fevertree, which manufactures tonic waters and other drinks, they have gone up 270%. But he said, ‘we continue to own the shares because we still see a lot of growth. Fevertree has done very well since it came to market. But actually it is still only 1% of the global; spirits market, and so there is scope for a lot more growth. You couldn’t really argue that Fevertree is an undervalued, or that it is a typical value stock. But I think it will grow into its current valuation.’ Fevertree is the third largest investment in the £500 million Standard Life Global Smaller Companies fund, which has returned 113% over the past five years, compared with 80% for the average fund in the IA Global Sector in the same time period. hTtp://www.whatinvestment.co.uk/no-threat-hsbc-dividend-following-latest-results-2553582/
07/9/2017
10:31
christh: Next milestone for Fevertree possible entry to the main market and lifted to the ftse350. That is if the directors deem it will be more profitable for the company but that's how some of the most succesful companies started. Fever-Tree is now sold in over 50 countries and is market capitalization is over £1 billion. The share price should be around £27 with the growth that is developping.
13/7/2017
10:07
christh: Consensus recommendation As of Jul 07, 2017, the consensus forecast amongst 4 polled investment analysts covering Fevertree Drinks PLC advises that the company will outperform the market. This has been the consensus forecast since the sentiment of investment analysts deteriorated on May 05, 2017. The previous consensus forecast advised investors to purchase equity in Fevertree Drinks PLC. Share price forecast The 3 analysts offering 12 month price targets for Fevertree Drinks PLC have a median target of 1,865.00, with a high estimate of 1,950.00 and a low estimate of 1,850.00. The median estimate represents a 8.75% increase from the last price of 1,715.00. Dividends In 2016, Fevertree Drinks PLC reported a dividend of 0.06 GBP, which represents a 102.92% increase over last year. The 4 analysts covering the company expect dividends of 0.07 GBP for the upcoming fiscal year, an increase of 13.60%. Fevertree Drinks Plc had revenues for the full year 2016 of 102.24m. This was 72.54% above the prior year's results. My comments The 2017 results are comfortably ahead of expectations (CEO comments)so there may be a significant growth above that. So well justified price target by the analysts. Read all in here in the Financial Times hTtps://markets.ft.com/data/equities/tearsheet/forecasts?s=FEVR:LSE&mhq5j=e2
22/6/2017
17:07
sogoesit: The article excerpt referred to in post 1013: "Fevertree (FEVR:AIM) £16.05 Current market status: LOVED Fevertree’s tonic water is increasingly the gin lover’s mixer of choice as it is considered a high quality product. The company has succeeded in getting its products stocked in a wide range of places, from supermarkets and restaurants to airlines and pubs. Fevertree has an asset-light, outsourced production model that means it is very cash generative and able to pay a progressive dividend. Its share price has risen 12-fold in value since joining the stock market in 2014. It has developed a reputation for providing conservative earnings guidance to analysts and subsequently over-delivering when financial numbers are reported. That has led to a continuous stream of earnings upgrades which have fuelled significant share price gains. FEVR - Comparison Line Chart (Rebased to first) WHAT ARE THE NEGATIVE POINTS FOR THE INVESTMENT CASE? 1. Could struggle to crack dark spirit market It is betting on a repeat of its tonic water success in the dark spirit mixers category. We think that’s a tall order. The market could punish the share price if the company cannot crack this market to same degree as it has done with light spirit mixers. Gin (a light spirit) and tonic is a refreshing drink where consumers clearly want high quality from both the spirit and the mixer, hence why Fevertree has done so well. However, dark spirits tend to be drunk neat, such as brandy, bourbon and whisky, so no need for fancy mixers. A mixer could cover up the true taste of whisky, for example, which defeats the object of enjoying that type of spirit. Water or ice would be acceptable mixers for whisky, but you don’t need a Fevertree-branded product. As for something like whisky and cola, surely that is the preferred drink of someone who is going after quantity over quality? Fevertree is now selling Madagascan Cola, which it claims to enhance ‘the complex flavours’ of the finest rums, whiskies and bourbons. Convincing shophisticated whisky drinkers to start adding cola to their favourite tipple will be a hard sell, in our opinion. 2. Is the business really worth £1.8bn? We note that Charles Rolls, one of the company’s founders and deputy chairman, last month sold £73.1m worth of shares. He cashed in £17.3m worth of shares when the company floated three years ago, plus earned £648,000 from Fevertree in pay and bonuses in 2016 alone – so hardly short of cash. Selling a large chunk now sends a negative signal to the market about the company’s future prospects. 3. Main Market plans We’ve heard talk that Fevertree is going to move to London’s Main Market. The company’s advisers say there are no plans at present, but we see this as a short-term risk to the share price if it does happen. The stock is a popular choice for investors wanting AIM shares that qualify for inheritance tax benefits. IHT portfolio managers would be forced to sell if Fevertree went to the Main Market as the shares would no longer qualify for the tax benefits."
10/6/2017
12:13
henchard: Here are some actual numbers for 2016 and forecast numbers for 2017 and 2018 (based on the current share price of 1,714p): ..........2016.....2017.....2018 EPS.......23.86p...27.68p...31.06p Growth....106.2%...16.0%....12.2% P/E.......71.8x....61.9x....55.2x Surely the shares are way too high at these P/Es for the forecast growth. The PEG ratio for 2017 is 3.9. For the PEG to get to the "fair value" benchmark of 1 (let alone a "growth-at-a-reasonable-price" level of below 1) FEVR would have to do EPS of 35.4p in 2017, which is 28% higher than the current consensus and 22% higher than the most bullish analyst, who's forecasting 29p EPS according to the FT. I could see FEVR beating EPS forecasts but not to the extent of 35.4p or higher. The alternative, of course, is that the share price would have to fall significantly for the valuation to become attractive.
15/5/2017
08:33
topvest: What a great company this is. Trouble is that the share price is now so high that an AHEAD profit update is already priced in. More downside than upside in the share price if you ask me. If you logically put a cap on how much this brand could ultimately be worth (top-end) it can't be much more than £3-5bn and its already valued at £2bn. Just my view. Obviously I wasn't smart enough to spot this great company 2/3 years ago so well done to those that spotted this early.
06/4/2017
15:29
greek islander: New high of 1553 reached before a pull back. Share price looking stronger than ever. More news inside the next 2-3 months about current trading should further inflate the share price The market needs reassurance that revenue continues to rise and then we shall be looking at £20. wetdream, the Asos pe may look ridiculous but it has been double that and more in the past. It is the clear market leader with a huge loyal following and though I no longer hold it after cashing in at just under £40 more than a couple of years back. It has nearly always had the potential to be a £100 stock. Be interesting to see if FEVR which has more international revenue and therefore potential gets there before it.
Fevertree share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V: D:20170926 20:17:06